Biogen Inc. - Common Stock — Cash Flow (NASDAQ:BIIB) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities 4.23 B3.64 B1.38 B1.55 B2.88 B2.2 B 2.59 B Cash from investing activities -608.6 M-563.7 M1.58 B-4.1 B-799.2 M-1.37 B -1.53 B Cash from financing activities -5.27 B-2.09 B-1.75 B149.3 M-683.5 M-301.9 M -322.7 M Free cash flow 4.23 B3.64 B1.38 B1.55 B2.88 B2.2 B 2.59 B

News

Biogen Inc. (BIIB) Presents at Alzheimer's Association International Conference (AAIC Meeting) 2026 - Slideshow (NASDAQ:BIIB) 2026-07-14

Biogen Inc. (BIIB) Presents at Alzheimer's Association International Conference (AAIC Meeting) 2026 Transcript

Stocks Settle Higher on Tame Inflation News

Biogen Wins FDA Approval for Subcutaneous Starter Dose of Leqembi

Ionis Begins Dosing in Phase I/II Dravet Syndrome Study

Biogen Slumps As Alzheimer's Study Leaves 'More Questions Than Answers'

Stocks Settle Lower as Chipmakers Routed and US-Iran Tensions Escalate

Stocks Retreat on Chipmaker Weakness and US-Iran Standoff

Stocks Fall on Weakness in Chipmakers and Renewed US-Iran Hostilities

Biogen's Q2 2026 Earnings: What to Expect

DNLI Stock Surges 59.4% Year to Date: Is There More Room for Growth?

IONS Completes Enrollment in Pivotal Cohort of Angelman Syndrome Study